AIM IMMUNOTECH INC. Professional Fees
AIM IMMUNOTECH INC. (AIM) reported Professional Fees of $21.00 thousand for the 12-month period ending 2013-12-31, per its 10-K filed 2014-03-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ProfessionalFees · last filed 2014-03-14
- AIM IMMUNOTECH INC. professional fees for fiscal 2013 was $21.00K, a 0.00% change from fiscal 2012.
- AIM IMMUNOTECH INC. professional fees for fiscal 2012 was $21.00K, a 300.00% increase from fiscal 2011.
- AIM IMMUNOTECH INC. professional fees for fiscal 2011 was $5.25K, a 99.67% decline from fiscal 2010.
- AIM IMMUNOTECH INC. professional fees for fiscal 2010 was $1.61M.
| Period end | Professional Fees 12 month | Professional Fees 12 month as first filed |
|---|---|---|
| 2013-12-31 | $21.00K 10-K · filed 2014-03-14 | |
| 2012-12-31 | $21.00K 10-K · filed 2014-03-14 | $1.56M 10-K · filed 2013-03-18 |
| 2011-12-31 | $5.25K 10-K · filed 2014-03-14 | $1.58M 10-K · filed 2013-03-18 |
| 2010-12-31 | $1.61M 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |